NASDAQ : VMD
Viemed Healthcare, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 9.95 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 378.98M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 359.55M |
| Enterprise Value | 360.47M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 38.09M |
| Shares Outstanding | 38.09M |
| Shares Change (YoY) | -1.92% |
| Shares Change (QoQ) | +1.57% |
| Owned by Insiders (%) | 13.93% |
| Owned by Institutions (%) | 62.96% |
| Float | 30.64M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 26.18 |
| Forward PE | 19.01 |
| PS Ratio | 1.19 |
| Forward PS | 1.08 |
| PB Ratio | 2.50 |
| P/TBV Ratio | 4.28 |
| P/FCF Ratio | 12.30 |
| P/OCF Ratio | 5.92 |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 24.86 |
| EV / Sales | 1.20 |
| EV / EBITDA | 6.46 |
| EV / EBIT | 14.11 |
| EV / FCF | 12.33 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.13 |
| Quick Ratio | 0.90 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.20 |
| Debt / FCF | 0.40 |
| Interest Coverage | 17.94 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 10.45% |
| Return on Assets (ROA) | 8.21% |
| Return on Invested Capital (ROIC) | 12.27% |
| Return on Capital Employed (ROCE) | 16.34% |
| Weighted Average Cost of Capital (WACC) | 9.94% |
| Revenue Per Employee | $209,740 |
| Profits Per Employee | $10,082 |
| Employee Count | 1,438 |
| Asset Turnover | 1.55 |
| Inventory Turnover | 26.75 |
Taxes
| Measure | Value |
|---|
| Income Tax | 6.16M |
| Effective Tax Rate | 29.05% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.04 |
| 52-Week Price Change | +46.13% |
| 50-Day Moving Average | 9.24 |
| 200-Day Moving Average | 9.58 |
| Relative Strength Index (RSI) | 46.50 |
| Average Volume (20 Days) | 199,870 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 1.54M |
| Short Previous Month | 1.57M |
| Short % of Shares Out | 4.03% |
| Short % of Float | 5.01% |
| Short Ratio (days to cover) | 5.97 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 301.61M |
| Gross Profit | 173.32M |
| Operating Income | 25.55M |
| Pretax Income | 21.18M |
| Net Income | 14.50M |
| EBITDA | 55.80M |
| EBIT | 25.55M |
| Earnings Per Share (EPS) | $0.36 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 10.68M |
| Total Debt | 11.60M |
| Net Cash | -920,000 |
| Net Cash Per Share | -$0.02 |
| Equity (Book Value) | 145.96M |
| Book Value Per Share | 3.78 |
| Working Capital | 6.07M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 60.78M |
| Capital Expenditures | -31.55M |
| Depreciation & Amortization | 30.25M |
| Net Borrowing | 3.05M |
| Free Cash Flow | 29.24M |
| FCF Per Share | $0.77 |
Margins
| Measure | Value |
|---|
| Gross Margin | 57.47% |
| Operating Margin | 8.47% |
| Pretax Margin | 7.02% |
| Profit Margin | 4.81% |
| EBITDA Margin | 18.50% |
| EBIT Margin | 8.47% |
| FCF Margin | 9.69% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | 1.92% |
| Shareholder Yield | 1.92% |
| Earnings Yield | 3.82% |
| FCF Yield | 8.13% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $12.50 |
| Price Target Difference | 32.42% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 13.97% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 5.82 |
| Piotroski F-Score | 5 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |